Physician Reluctance to Intervene in Addiction
Ärztliche Zurückhaltung bei Interventionen bei Suchterkrankungen
JAMA Network Open · 17.07.2024 · 7 (7) · e2420837
DOI: 10.1001/jamanetworkopen.2024.20837 ↗Auf einen Blick
Die systematische Übersichtsarbeit beschreibt Gründe für die ärztliche Zurückhaltung bei Maßnahmen gegen Substanzgebrauch und Abhängigkeit. Am häufigsten genannt wurden fehlende institutionelle Unterstützung, Wissen, Fertigkeiten und kognitive Kapazität.
Fragestellung
Welche Gründe nennen Ärzt:innen für ihre Zurückhaltung, Substanzgebrauch und Abhängigkeit in der Praxis mit Screening, Behandlung, Harm-Reduction oder Recovery-Support anzugehen?
Methode
Systematische Übersichtsarbeit nach PRISMA; Suche in PubMed, Embase, Scopus, medRxiv und SSRN Medical Research Network bis 5. Oktober 2021; theoretischer Domains-Rahmen zur Extraktion der Gründe.
Ergebnisse
183 von 9308 Treffern mit Daten von 66 732 Ärzt:innen wurden eingeschlossen. Häufigste Gründe: fehlende institutionelle Unterstützung, Wissen, Skill und kognitive Kapazität. Auch Vergütungsbedenken wurden genannt.
Einschränkungen
Überwiegend Survey-Daten; bivariate Analysen zu Fachgebiet, Interventionstyp und Substanz.
Schlussfolgerung der Autor:innen
Die Autor:innen schließen, dass die häufigsten Gründe fehlende institutionelle Unterstützung, Wissen, Skill und kognitive Kapazität waren. Bildung, Training, Politikentwicklung und Programmumsetzung könnten die Nutzung von EBPs verbessern.
Kernaussagen
- 183 eingeschlossene Publikationen mit Daten von 66 732 Ärzt:innen
- Häufigste Gründe: Unterstützung, Wissen, Skill und kognitive Kapazität
- Zusammenhänge mit Fachgebiet, Interventionstyp und Substanz
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift JAMA Network Open, online erschienen am 17.07.2024. Verfasst von Melinda Campopiano von Klimo und 7 weiteren Autor:innen. Beteiligte Einrichtung: JBS International, Inc, North Bethesda, Maryland. Hauptthemen laut MEDLINE: Substance-Related Disorders. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 313 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Importance The overdose epidemic continues in the US, with 107 941 overdose deaths in 2022 and countless lives affected by the addiction crisis. Although widespread efforts to train and support physicians to implement medications and other evidence-based substance use disorder interventions have been ongoing, adoption of these evidence-based practices (EBPs) by physicians remains low.
Objective
To describe physician-reported reasons for reluctance to address substance use and addiction in their clinical practices using screening, treatment, harm reduction, or recovery support interventions. Data Sources A literature search of PubMed, Embase, Scopus, medRxiv , and SSRN Medical Research Network was conducted and returned articles published from January 1, 1960, through October 5, 2021. Study Selection Publications that included physicians, discussed substance use interventions, and presented data on reasons for reluctance to intervene in addiction were included. Data Extraction and Synthesis Two reviewers (L.N., M.C., L.F., J.P., C.S., and S.W.) independently reviewed each publication; a third reviewer resolved discordant votes (M.C. and W.C.). This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines and the theoretical domains framework was used to systematically extract reluctance reasons. Main Outcomes and Measures The primary outcome was reasons for physician reluctance to address substance use disorder. The association of reasons for reluctance with practice setting and drug type was also measured. Reasons and other variables were determined according to predefined criteria.
Results
A total of 183 of 9308 returned studies reporting data collected from 66 732 physicians were included. Most studies reported survey data. Alcohol, nicotine, and opioids were the most often studied substances; screening and treatment were the most often studied interventions. The most common reluctance reasons were lack of institutional support (173 of 213 articles [81.2%]), knowledge (174 of 242 articles [71.9%]), skill (170 of 230 articles [73.9%]), and cognitive capacity (136 of 185 articles [73.5%]). Reimbursement concerns were also noted. Bivariate analysis revealed associations between these reasons and physician specialty, intervention type, and drug. Conclusions and Relevance In this systematic review of reasons for physician reluctance to intervene in addiction, the most common reasons were lack of institutional support, knowledge, skill, and cognitive capacity. Targeting these reasons with education and training, policy development, and program implementation may improve adoption by physicians of EBPs for substance use and addiction care. Future studies of physician-reported reasons for reluctance to adopt EBPs may be improved through use of a theoretical framework and improved adherence to and reporting of survey development best practices; development of a validated survey instrument may further improve study results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- JBS International, Inc, North Bethesda, Maryland.
- National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
- Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
- National Survivors Union, Greensboro, North Carolina.
- NC Survivors Union, Greensboro, North Carolina.
- Whose Corner Is It Anyway, Holyoke, Massachusetts.
Zitieren
APA
Campopiano von Klimo, M., Nolan, L., Corbin, M., Farinelli, L., Pytell, J. D., Simon, C., Weiss, S. T., & Compton, W. M. (2024). Physician Reluctance to Intervene in Addiction. JAMA Network Open, 7(7), e2420837. https://doi.org/10.1001/jamanetworkopen.2024.20837
Vancouver
Campopiano von Klimo M, Nolan L, Corbin M, Farinelli L, Pytell JD, Simon C, et al. Physician Reluctance to Intervene in Addiction. JAMA Network Open. 2024;7(7):e2420837. doi:10.1001/jamanetworkopen.2024.20837
BibTeX
@article{CampopianovonKlimo2024,
author = {Campopiano von Klimo, Melinda and Nolan, Laura and Corbin, Michelle and Farinelli, Lisa and Pytell, Jarratt D and Simon, Caty and Weiss, Stephanie T and Compton, Wilson M},
title = {Physician Reluctance to Intervene in Addiction},
journal = {JAMA Network Open},
year = {2024},
volume = {7},
number = {7},
pages = {e2420837},
doi = {10.1001/jamanetworkopen.2024.20837}
}
EUVIMED